Creatine monohydrate supplements raised serum creatine values in Alzheimer's disease patients in a pilot trial. Preliminary secondary outcome results showed positive trends on brain total creatine ...

INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early stages of the mind-robbing disease in a mid-stage study, sending its shares ...

CHARLESTON, W.Va. –A new app aiming to help those with early stages of Alzheimer’s and their caretakers navigate their diagnoses has been launched by the Alzheimer’s Association. The My ALZ ...

Research finds combining EEG/ERP and vMRI improves accuracy in diagnosing cognitive decline, supporting Firefly's recent acquisition of Evoke Neuroscience.

San Jose councilmember Michael Mulcahy walks across the finish line in The YWCA Golden Gate Silicon Valley’s annual Walk A Mile in Their Shoes at Santana Row in San Jose, Calif., on Friday, June ...

A compound derived from rosemary, known as carnosic acid, has been transformed into a potent brain-boosting drug that combats Alzheimer’s by reducing inflammation and stress in the brain — all ...

In an unprecedented large-scale study, researchers have mapped out the first molecular events that cause harmful protein buildups in the brain of people with Alzheimer's disease. "By measuring the ...

New Alzheimer's treatment uses CAR T-cell tech to target brain plaques, offering a precise approach with fewer side effects than current drugs.

(WJW) — Fat Little Buddies, of Olmsted Township, has a full weekend planned to raise money for a good cause. The group has been raising funds for the Alzheimer’s Association for the last 15 ...

Research published 30 years ago made a connection between HSV-1 and Alzheimer's disease. Doctors weigh in on how relevant (or not) it remains.

NewAmsterdam Pharma’s push to show a cholesterol drug can prevent Alzheimer’s disease has passed another test. The phase 3 sub-study tracked significant changes in an Alzheimer’s biomarker ...

Research published 30 years ago made a connection between HSV-1 and Alzheimer's disease. Doctors weigh in on how relevant (or not) it remains.